Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children

Supportive Care in Cancer

Volumn 22, Issue 2, 2014, Pages 359-366

  Gilchrist, L S ^a,b   Marais, L ^c   Tanner, L ^b  

^a ST CATHERINE UNIVERSITY   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c St Croix Therapy   (United States)

Author keywords

Cancer; Neurotoxicity; Pediatrics

Indexed keywords

CISPLATIN; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CHILD; DRUG INDUCED DISEASE; EWING SARCOMA; FEMALE; HEPATOBLASTOMA; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOTOR NEUROPATHY; NEPHROBLASTOMA; NERVE CELL LESION; NEUROLOGIC EXAMINATION; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SENSORY NEUROPATHY; YOUNG ADULT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; LYMPHOMA; MALE; NEOPLASMS; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; VINCRISTINE;

EID: 84896028812     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1981-6     Document Type: Article

References (27)

1. Hausheer FH, Schilsky RL, Bain S et al (2006) Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33:15-49 (Pubitemid 43214485)
2. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy-induced peripheral neurotoxicity: an update. Crit Rev Oncol Hematol 82:51-77
3. Jaggi AS, Singh N (2012) Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 291:1-9
4. Sioka C, Kyritsis AP (2009) Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 63:761-767
5. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549-1563 (Pubitemid 36976138)
6. Driessen CML, de Kleine-Bolt KME, Vingerhoets AJJM et al (2012) Addressing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients. Support Care Cancer 20:877-881
7. Gilchrist LS, Tanner L (2013) The pediatric-modified Total Neuropathy Score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer 21(3):847-856
8. Ness KK, Hudson MM, Pui CH et al (2012) Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer 118(3):828-838
9. Sung L, Zaoutis T, Ullrich NJ, Johnston D, Dupuis L, Ladas E, Children's Oncology Group Cancer Control and Supportive Care Committee (2013) Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care. Pediatr Blood Cancer 60(6):1027-1030
10. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (2006); http://ctep.cancer.gov/protocolDevelopment/ electronic-applications/docs/ctcaev3.pdf; Accessed August 1, 2008
11. Muscal JA, Thompson PA, Horton TM et al (2013) A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumor: a Children's Oncology Group phase 1 consortium study (ADVL0916). Pediatr Blood Cancer 60(3):390-395
12. Messinger YH, Gayon PS, Sposto R et al (2012) Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) study. Blood 120(2):285-290
13. Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176-181 (Pubitemid 36962641)
14. Ness KK, Jones KE, Smith WA, Spunt SL, Wilson CL, Armstrong GT, Srivastava DK, Robison LL, Hudson MM, Gurney JG (2013) Chemotherapy-related neuropathic symptoms and functional impairments in adult survivors of extracranial solid tumors of childhood: results from the St. Jude lifetime cohort study. Arch Phys Med Rehabil. doi:10.1016/j.apmr.2013.03.009
15. Ramchandren S, Leonard M, Mody RJ et al (2009) Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 14(3):184-189
16. Atkinson TM, Li Y, Coffey CW, Sit L et al (2012) Reliability of adverse symptom event reporting by clinicians. Qual Life Res 21(7):1159-1164
17. Cirillo M, Venturini M, Ciccarelli L et al (2009) Clinician versus nurse symptom reporting using the National Cancer Institute - Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire. Ann Oncol 20(12):1929-1935
18. Frigeni B, Piatti M, Lanzani F et al (2011) Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. J Peripher Nerv Syst 16:228-236
19. Gilchrist LS, Tanner L, Hooke MC (2009) Measuring chemotherapy-induced peripheral neuropathy in children: development of the ped-mTNS and pilot study results. Rehabil Oncol 27(3):7-15
20. Bell JA (1984) Semmes-Weinstein monofilament testing for determining cutaneous light touch/deep pressure sensation. Star 44:8-11
21. Medical Research Council of the United Kingdom (1978) Aids to examination of the peripheral nervous system: memorandum no 45. Pedragon House, Palo Alto
22. Delanian S, Lefaix JL, Pradat PF (2012) Radiation-induced neuropathy in cancer survivors. Radiother Oncol 105(3):273-282
23. Stubblefield MD, Burstein HJ, Burton AW et al (2009) NCCN task force report: management of neuropathy in cancer. J Natl Compr Cancer Network 7(Suppl 5):S1-S26
24. Cavaletti G, Frigeni B, Lanzani F et al (2007) The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst 12:210-215 (Pubitemid 47404378)
25. Verstappen CC, Koeppen S, Heimans JJ et al (2005) Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology 64(6):1076-1077 (Pubitemid 40388469)
26. Lavoie Smith EM, Cohen JA, Pett MA, Beck SL (2011) The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums. Oncol Nurs Forum 38(2):133-142
27. Wampler MA, Miaskowski C, Hamel K et al (2006) The modified total neuropathy score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. J Support Oncol 4:9-16